Form 4 for MUSA Murphy USA Inc.
Accepted 2026-02-13 00:00:00 ET · period of report 2026-02-11 · accession 0001573516-26-000050 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-02-13 | 2026-02-11 | MUSA | Bacon Renee M | SVP, Sales, Ops | F - Tax | $363.36 | -792 | 7,146 | -10% | -$287.8K |
| D | 2026-02-13 | 2026-02-13 | MUSA | Bacon Renee M | SVP, Sales, Ops | S - Sale+OE | $386.09 | -1,219 | 5,927 | -17% | -$470.6K |
| D | 2026-02-13 | 2026-02-11 | MUSA | Bacon Renee M | SVP, Sales, Ops | M - OptEx | $0.00 | +2,011 | 7,938 | +34% | $0 |
| DM | 2026-02-13 | 2026-02-11 | MUSA | Bacon Renee M | SVP, Sales, Ops | A - Grant | $0.00 | +3,857 | 2,450 | New | $0 |
| D | 2026-02-13 | 2026-02-11 | MUSA | Bacon Renee M | SVP, Sales, Ops | M - OptEx | $0.00 | -1,200 | 2,435 | -33% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-02-11 | F | D | 792 | $363.36 | 7,146.30 | D | — | — | |
| 2 | Common | Common Stock | 2026-02-13 | S | D | 1,219 | $386.09 | 5,927.30 | D | — | — | |
| 3 | Common | Common Stock | 2026-02-11 | M | A | 2,011 | $0.00 | 7,938.30 | D | — | — | (F1) Represents performance-based restricted Stock units that have vested and settled in shares of the Company's stock. Pursuant to the terms of the performance-based grant, the total includes 165.3% of the original award plus shares equivalent in value to accumulated dividends. |
| 4 | Derivative | Stock Option | 2026-02-11 | A | A | 1,378 | $0.00 | 1,378 | D | $380.92 · — to 2033-02-11 | 1,378 Common Stock | (F4) Awarded under the 2023 Omnibus Incentive Plan. (F5) The option vests in two equal installments, the first half two years after the grant date and the final half three years after the grant date. |
| 5 | Derivative | Restricted Stock Unit | 2026-02-11 | A | A | 418 | $0.00 | 1,224.09 | D | — · — to — | 418 Common Stock | (F4) Awarded under the 2023 Omnibus Incentive Plan. (F7) Includes dividend equivalent units accrued with respect to the underlying RSUs. (F6) These Securities generally do not carry a Conversion Price, Exercisable Date, or Expiration Date. |
| 6 | Derivative | Performance Stock Unit | 2026-02-11 | M | D | 1,200 | $0.00 | 2,435 | D | — · — to — | 1,200 Common Stock | (F8) Award granted under the 2013 Long-Term Incentive Plan. (F6) These Securities generally do not carry a Conversion Price, Exercisable Date, or Expiration Date. |
| 7 | Derivative | Performance Stock Unit | 2026-02-11 | A | A | 835 | $0.00 | 3,635 | D | — · — to — | 835 Common Stock | (F4) Awarded under the 2023 Omnibus Incentive Plan. (F6) These Securities generally do not carry a Conversion Price, Exercisable Date, or Expiration Date. |
| 8 | Derivative | Restricted Stock Unit | 2026-02-11 | A | A | 1,226 | $0.00 | 2,450.09 | D | — · — to — | 1,226 Common Stock | (F4) Awarded under the 2023 Omnibus Incentive Plan. (F7) Includes dividend equivalent units accrued with respect to the underlying RSUs. (F6) These Securities generally do not carry a Conversion Price, Exercisable Date, or Expiration Date. |